Oncology Institute (TOIIW) Receivables - Other (2020 - 2026)

Oncology Institute (TOIIW) has reported Receivables - Other for 7 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

• Receivables - Other for Q1 2026 came in at $1.3 million, up 280.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 280.35% YoY), and the FY2025 annual result was $322000.0, down 6.94% from the prior year.
• Receivables - Other was $1.3 million for Q1 2026 at Oncology Institute, up from $322000.0 in the prior quarter.
• Over five years, Receivables - Other peaked at $1.3 million in Q1 2026 and troughed at $276000.0 in Q2 2025.
• Average Receivables - Other over 5 years is $520000.0, with a median of $422000.0 recorded in 2022.
• Year-over-year, Receivables - Other tumbled 66.54% in 2023 and jumped 280.35% in 2026.
• Over 5 years, Receivables - Other stood at $617000.0 in 2022, then decreased by 10.7% to $551000.0 in 2023, then plunged by 37.21% to $346000.0 in 2024, then decreased by 6.94% to $322000.0 in 2025, then surged by 308.7% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Receivables - Other figures were $1.3 million in Q1 2026, $322000.0 in Q4 2025, and $339000.0 in Q3 2025.